Pheton Holdings Ltd (PTHL)
NASDAQ: PTHL · Real-Time Price · USD
4.170
+0.060 (1.46%)
Dec 20, 2024, 4:00 PM EST - Market closed

Company Description

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.

The company’s proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.

Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.

The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.

Pheton Holdings Ltd
Pheton Holdings logo
Country China
Founded 1998
IPO Date Sep 5, 2024
Industry Medical Devices
Sector Healthcare
Employees 11
CEO Jianfei Zhang

Contact Details

Address:
NET Building, Room 306
Beijing, 100101
China
Phone 86 10 8481 7665
Website ftzy.com.cn

Stock Details

Ticker Symbol PTHL
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.00
CIK Code 0001970544
ISIN Number KYG713991027
SIC Code 3845

Key Executives

Name Position
Jianfei Zhang Chief Executive Officer and Chairman of the Board
Zhixin Li Chief Financial Officer

Latest SEC Filings

Date Type Title
Oct 15, 2024 6-K Report of foreign issuer
Sep 9, 2024 6-K Report of foreign issuer
Sep 6, 2024 424B4 Prospectus
Sep 4, 2024 EFFECT Notice of Effectiveness
Sep 3, 2024 CERT Certification by an exchange approving securities for listing
Aug 30, 2024 8-A12B Registration of securities
Aug 5, 2024 POS EX Filing
Jun 18, 2024 POS AM Post-Effective amendments for registration statement
May 3, 2024 SP 15D2 Filing
May 3, 2024 POS AM Post-Effective amendments for registration statement